Multiple ferroptosis-associated regulators, such as glutathione (GSH), glutathione peroxidase 4 (GPX4), NFE2L2, superoxide dismutase (SOD), lipoxygenase, and coenzyme Q, are capable of remodeling breast cancer progression (9). This evidence concerns the gene GPX4 and breast carcinoma.